Gao X, Shen S, Xiang W, Song X
Clin Cosmet Investig Dermatol. 2024; 17:1423-1428.
PMID: 38911340
PMC: 11192638.
DOI: 10.2147/CCID.S466881.
Bohmwald K, Diethelm-Varela B, Rodriguez-Guilarte L, Rivera T, Riedel C, Gonzalez P
Front Immunol. 2024; 15:1341600.
PMID: 38482000
PMC: 10932978.
DOI: 10.3389/fimmu.2024.1341600.
Azrielant S, Levin Y, Peled A, Samuelov L, Sprecher E, Pavlovsky M
Acta Derm Venereol. 2024; 104:adv18389.
PMID: 38348725
PMC: 10875474.
DOI: 10.2340/actadv.v104.18389.
Leeyaphan C, Jirawattanadon P, Bunyaratavej S, Panjapakkul W, Hutachoke T, Nanchaipruek Y
Dermatol Res Pract. 2024; 2023:2206498.
PMID: 38188702
PMC: 10771922.
DOI: 10.1155/2023/2206498.
Thada P, Ata F, Ali M, Affas M, Bhandari J, Sarwar S
Qatar Med J. 2022; 2022(3):41.
PMID: 36187753
PMC: 9483766.
DOI: 10.5339/qmj.2022.41.
Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights.
Martinez-Reviejo R, Tejada S, Adebanjo G, Chello C, Machado M, Parisella F
Eur J Intern Med. 2022; 104:73-79.
PMID: 35931613
PMC: 9340059.
DOI: 10.1016/j.ejim.2022.07.022.
Characteristics of herpes zoster infection in patients with COVID-19: a systematic scoping review.
Czech T, Nishimura Y
Int J Dermatol. 2022; 61(9):1087-1092.
PMID: 35503921
PMC: 9347482.
DOI: 10.1111/ijd.16221.
Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination.
Almutairi N, Almutairi A, Almazyad M, Alwazzan S
Dermatol Ther. 2022; 35(7):e15521.
PMID: 35434963
PMC: 9111648.
DOI: 10.1111/dth.15521.
: A Review of Clinical Manifestations and Management.
Patil A, Goldust M, Wollina U
Viruses. 2022; 14(2).
PMID: 35215786
PMC: 8876683.
DOI: 10.3390/v14020192.
Cervical and preauricular lymphadenopathies as atypical manifestations in the setting of COVID-19: a case report.
Ala A, Habtemariam S, Shams Vahdati S, Rezabakhsh A
Future Virol. 2022; .
PMID: 35186108
PMC: 8846295.
DOI: 10.2217/fvl-2021-0074.
COVID-19 Rekindling Herpes Zoster in an Immunocompetent Patient.
Puri P, Parnami P, Athwal P, Kumari S, Kumar C, Suri Y
Cureus. 2021; 13(9):e18049.
PMID: 34692281
PMC: 8523338.
DOI: 10.7759/cureus.18049.
Herpes zoster after COVID vaccination.
van Dam C, Lede I, Schaar J, Al-Dulaimy M, Rosken R, Smits M
Int J Infect Dis. 2021; 111:169-171.
PMID: 34428545
PMC: 8379763.
DOI: 10.1016/j.ijid.2021.08.048.
Herpes simplex and herpes zoster viruses in COVID-19 patients.
Katz J, Yue S, Xue W
Ir J Med Sci. 2021; 191(3):1093-1097.
PMID: 34247308
PMC: 8272836.
DOI: 10.1007/s11845-021-02714-z.
A rare case of shingles after COVID-19 vaccine: is it a possible adverse effect?.
Aksu S, Ozturk G
Clin Exp Vaccine Res. 2021; 10(2):198-201.
PMID: 34222134
PMC: 8217581.
DOI: 10.7774/cevr.2021.10.2.198.
Synthesis and Evaluation of Some Uracil Nucleosides as Promising Anti-Herpes Simplex Virus 1 Agents.
Mohamed Awad S, Ali S, Mansour Y, Fatahala S
Molecules. 2021; 26(10).
PMID: 34069874
PMC: 8157375.
DOI: 10.3390/molecules26102988.
Hemorrhagic herpes zoster with contralateral multidermatomal distribution associated with rivaroxaban: An unusual presentation.
Sowell J, Reynolds H, Sowell J
JAAD Case Rep. 2021; 9:31-33.
PMID: 33604441
PMC: 7876518.
DOI: 10.1016/j.jdcr.2020.12.038.
Increased number of Herpes Zoster cases in Brazil related to the COVID-19 pandemic.
Maia C, Marques N, Lucena E, de Rezende L, Martelli D, Martelli-Junior H
Int J Infect Dis. 2021; 104:732-733.
PMID: 33582367
PMC: 7877899.
DOI: 10.1016/j.ijid.2021.02.033.
